Dexmedetomidine: An All Sedation-in-One Drug in Critically Ill Patients with COVID-19
Saved in:
Main Authors: | Ata Mahmoodpoor (Author), Elyad Ekrami (Author), Hassan Soleimanpour (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 Patients
by: Saeid Safari, et al.
Published: (2021) -
A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19
by: Ata Mahmoodpoor, et al.
Published: (2021) -
Dexmedetomidine Based Sedation for Post-surgery Critically Ill Adults: A Meta-analysis of Randomized Controlled Trials
by: Heng FAN, et al.
Published: (2017) -
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
by: Kavous Shahsavarinia, et al.
Published: (2021) -
Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
by: Chen-Fang Lee, et al.
Published: (2021)